Roe, M. T., Szarek, M., Li, Q. H., Bhatt, D. L., Bittner, V., Goodman, S. G., … Schwartz, G. G. (2019). Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy. In EUROPEAN HEART JOURNAL (Vol. 40, pp. 2474–2474). Paris, FRANCE: OXFORD UNIV PRESS.

Roe, M. T., M. Szarek, Q. H. Li, D. L. Bhatt, V. Bittner, S. G. Goodman, R. A. Harrington, et al. “Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy.” In EUROPEAN HEART JOURNAL, 40:2474–2474. OXFORD UNIV PRESS, 2019.

Roe MT, Szarek M, Li QH, Bhatt DL, Bittner V, Goodman SG, et al. Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2019. p. 2474–2474.

Roe, M. T., et al. “Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy.” EUROPEAN HEART JOURNAL, vol. 40, OXFORD UNIV PRESS, 2019, pp. 2474–2474.

Roe MT, Szarek M, Li QH, Bhatt DL, Bittner V, Goodman SG, Harrington RA, Lopez-Jaramillo P, Lopes RD, Louie MJ, Moriarty PM, Vogel RA, Baccara-Dinet MT, Steg PG, Schwartz GG. Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2019. p. 2474–2474.